MAGE-A3 mRNA Neoantigen Vaccine

MAGE-A3 mRNA Neoantigen Vaccine

SKU: BCVC01
495.00 USD In stock Buy at Merchant

MAGE-A3 mRNA neoantigen vaccine expresses human MAGE-A3 protein and, when packaged into LNP, triggers T-cell responses against MAGE-A3 neoantigens in tumors.

  • The description claims that the vaccine can trigger T-cell responses against tumors presenting MAGE-A3 neoantigens.
Specifications
Synthesis scale
100 ug, 500 ug, 1 mg

AI Readiness

Good foundation, but some important product data is still missing.

74%